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by mutations in CaV2.1 (P/Q-type) Ca
2þ channels. CaV2.1 channels play a key
role in initiating action potential-evoked neurotransmitter release at central
synapses. FHM1 mutations shift channel activation to lower voltages and in-
crease Ca2þ influx through single recombinant human CaV2.1 channels.
Knockin mice carrying a human FHM1 mutation show an increased P/Q-
type Ca2þ current in cerebellar and cortical neurons and a reduced threshold
for and increased velocity of cortical spreading depression (CSD), the phe-
nomenon that underlies migraine aura and may activate migraine headache
mechanisms. To investigate the mechanisms of CSD facilitation, we studied
neurotransmission at synapses of cortical pyramidal cells in microculture
and in connected pairs of layer 2/3 pyramidal cells and fast-spiking inter-
neurons in acute thalamocortical slices. Our data show increased strength
of excitatory neurotransmission due to enhanced action potential-evoked
Ca2þ influx through synaptic CaV2.1 channels and increased probability of
glutamate release at pyramidal cell synapses of FHM1 KI mice. At the
same synapses, short-term depression during trains of action potentials
was enhanced. There was no evidence of homeostatic compensatory mech-
anisms at synapses onto pyramidal cells. To investigate possible alterations
of the cortical excitation-inhibition balance in FHM1, we studied inhibitory
neurotransmission between fast-spiking interneurons and pyramidal cells in
thalamocortical slices. At this inhibitory synapse the strength of neurotrans-
mission was unaltered in KI mice. Our findings may explain CDS facilita-
tion in FHM1 mice, and point to tipping the finely tuned dynamic balance
between excitation and inhibition during cortical activity towards excitation
as the basis for CSD propensity and abnormal processing of sensory infor-
mation in migraine.
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Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative
disorder. Mutations in presenilins are responsible for approximately 40% of
all early onset familial Alzheimer’s disease (FAD) cases in which a genetic
cause has been identified. FAD mutations and genetic deletions of presenilins
have been linked with calcium (Ca2þ) signaling abnormalities, but mechanis-
tic basis for these results has not been clearly determined. Presenilins are
highly conserved transmembrane proteins that support cleavage of the amy-
loid precursor protein by gamma-secretase. In our studies we discovered
that in addition to acting as a gamma-secretase, presenilins also function as
passive endoplasmic reticulum calcium (Ca2þ) leak channels. We demon-
strate that wild type PS1 and PS2 proteins form low conductance divalent cat-
ion-permeable ion channels in planar lipid bilayers. In experiments with PS1/2
double knockout (DKO) mouse embryonic fibroblasts (MEFs) we discovered
that presenilins account for ~80% of passive Ca2þ leak from the endoplasmic
reticulum. The ER Ca2þ leak function of presenilins is independent from
their gamma-secretase function In additional experiments we demonstrated
that ER Ca2þ leak function of presenilins is impaired by M146V, L166P,
A246E, E273A, G384A and P436Q FAD mutations in PS1 and N141I muta-
tion in PS2. In contrast, FTD-associated mutations (L113P, G183V and
Rins352) did not appear to affect ER Ca2þ leak function of PS1 in our exper-
iments, indicating that the observed effects are disease-specific. Our data un-
cover a novel Ca2þ signaling function of presenilins and provide support to
the potential role of disturbed Ca2þ homeostasis in AD pathogenesis. We are
in the process of expanding these findings to neuronal system. Our latest find-
ings will be discussed.
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Mutations in skeletal muscle sodium channels (NaV1.4) cause periodic paraly-
sis. Paramyotonia congenita and hyperkalemic periodic paralysis are caused by
gain-of-function mutations spread widely through the protein, which increase
channel activity and lead to repetitive firing or depolarization block. In contrast,
mutations that cause hypokalemic (HypoPP) and normokalemic (NormoPP)
periodic paralysis are localized in the outermost three gating-charge-carrying
arginine residues (R1-R3) in the S4 segment in domain II, and they do not
have major effects on sodium channel function as typically measured. Site-di-
rected mutations of these residues cause gating pore current, a voltage-gated
leak current through the voltage sensor (Sokolov et al., 2005); mutations of
R1 and R2 cause gating pore current in the resting state, whereas mutation of
R3 causes gating pore current in the activated state. Similar studies of the Hy-
poPP mutant R2G revealed gating pore current of approximately 1% of peak
current at the resting membrane potential, which was decreased by depolariza-
tion (Sokolov et al., 2007). This gating pore current was selective for
Cs>K>Na and blocked by mM concentrations of divalent cations,
Zn>Ba>Ca. A gating pore current of similar size was observed in the resting
state for the HypoPP mutants R1H and R2H, but this current is selective for
protons. In contrast to HypoPP, the mutations that cause NormoPP are in R3
(R3G/Q/W). All of these mutations cause gating pore conductance for sodium
in the activated and slow-inactivated states, in which the voltage sensors are in
their outward position. The common pathogenic feature of these mutations is
likely to be depolarization and sodium overload, which are observed in patient
biopsies. Dominant gain-of-function pathogenic effects may arise directly from
excess sodium entry for R2G and R3G/Q/W and indirectly from excessive
Na-H exchange for R1H and R2H.
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The mechanism whereby missense mutations in charged residues of the S4 seg-
ments of CaV1.1 and NaV1.4 cause the skeletal muscle disorder hypokalemic
periodic paralysis (HypoPP) remains poorly understood. Recent work suggests
a possible common functional defect, in which HypoPP mutations produce ab-
errant ionic conductances flowing through the aqueous gating-pore in which the
mutant S4 segment resides. We observed low-amplitude gating-pore currents
for HypoPP mutations in the R1 and R2 positions of S4 in domain II in
NaV1.4. Several features of these HypoPP-associated gating pore conductances
were unexpected, and may provide insight into S4 segment function. For in-
stance, gating pores exposed by mutations at the R2 site exhibited marked cur-
rent saturation at hyperpolarized voltages. Saturation can be accounted for by
a model with a single cation binding site very near the external surface of
the electrical field. The ionic selectivity of different HypoPP gating pores is
dependent on the substituted residue: histidine substitutions causing proton-
selectivity, whereas other substitutions result in limited selectivity among
monovalent cations. The pathophysiological significance of this dichotomy re-
mains unclear. In addition, the low amplitude of the disease-associated gating
pore currents (~.1% of the peak Na current through the central pore) is probably
insufficient to directly cause the large depolarization of affected muscle fibers
during a paralytic attack. These small currents might predispose to episodic
paralysis by potentiating the normal sarcolemmal propensity to depolarize
upon reduction of external Kþ. This paradoxical depolarization is a conse-
quence of the Kþ dependence for the inward rectifier Kþ conductance, which
causes Vrest to deviate from Nernstian behavior. Thus, muscle fibers with an
inward gating-pore current may function normally at most times, but may
be poised for massive depolarization in the setting of minor perturbations of
extracellular [Kþ].
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Several years ago, the bioenergetics subgroup decided to broaden the more nar-
row definition of bioenergetics to include all pathways involved in energy pro-
duction. The importance of studying them in combination can be illustrated by
the very different metabolic behavior of cancer cells that, in contrast to healthy
cells, derive most of their energy from glycolysis and at the same time show
a lack of apoptosis. While each presentation in this workshop will be focused
on specific topics, glycolysis, the mitochondrial membrane system, the pyru-
vate dehydrogenase as part of the TCA cycle and the fumarate reductase as
one of the enzymes in the mitochondrial respiratory chain, emphasis will be
given to the interconnection between the different systems.
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